vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and DIODES INC (DIOD). Click either name above to swap in a different company.
DIODES INC is the larger business by last-quarter revenue ($391.6M vs $236.8M, roughly 1.7× CROSS COUNTRY HEALTHCARE INC). DIODES INC runs the higher net margin — 2.6% vs -35.0%, a 37.6% gap on every dollar of revenue. On growth, DIODES INC posted the faster year-over-year revenue change (15.4% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $12.4M). Over the past eight quarters, DIODES INC's revenue compounded faster (13.9% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Diodes Incorporated is a global semiconductor manufacturer that designs, produces and supplies discrete, analog and mixed-signal semiconductor products. Its solutions serve key end markets including automotive, industrial, consumer electronics, personal computing and communications infrastructure, with a worldwide customer base.
CCRN vs DIOD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $391.6M |
| Net Profit | $-82.9M | $10.2M |
| Gross Margin | — | 31.1% |
| Operating Margin | -30.2% | 3.4% |
| Net Margin | -35.0% | 2.6% |
| Revenue YoY | -23.6% | 15.4% |
| Net Profit YoY | -2109.7% | 23.8% |
| EPS (diluted) | $-2.56 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $391.6M | ||
| Q3 25 | $250.1M | $392.2M | ||
| Q2 25 | $274.1M | $366.2M | ||
| Q1 25 | $293.4M | $332.1M | ||
| Q4 24 | $309.9M | $339.3M | ||
| Q3 24 | $315.1M | $350.1M | ||
| Q2 24 | $339.8M | $319.8M | ||
| Q1 24 | $379.2M | $302.0M |
| Q4 25 | $-82.9M | $10.2M | ||
| Q3 25 | $-4.8M | $14.3M | ||
| Q2 25 | $-6.7M | $46.1M | ||
| Q1 25 | $-490.0K | $-4.4M | ||
| Q4 24 | $-3.8M | $8.2M | ||
| Q3 24 | $2.6M | $13.7M | ||
| Q2 24 | $-16.1M | $8.0M | ||
| Q1 24 | $2.7M | $14.0M |
| Q4 25 | — | 31.1% | ||
| Q3 25 | 20.4% | 30.7% | ||
| Q2 25 | 20.4% | 31.5% | ||
| Q1 25 | 20.0% | 31.5% | ||
| Q4 24 | — | 32.7% | ||
| Q3 24 | 20.4% | 33.7% | ||
| Q2 24 | 20.8% | 33.6% | ||
| Q1 24 | 20.4% | 33.0% |
| Q4 25 | -30.2% | 3.4% | ||
| Q3 25 | -2.4% | 3.0% | ||
| Q2 25 | -2.1% | 2.6% | ||
| Q1 25 | -0.3% | 0.4% | ||
| Q4 24 | -1.1% | 3.5% | ||
| Q3 24 | 0.9% | 6.2% | ||
| Q2 24 | -5.7% | 1.2% | ||
| Q1 24 | 0.8% | 4.3% |
| Q4 25 | -35.0% | 2.6% | ||
| Q3 25 | -1.9% | 3.6% | ||
| Q2 25 | -2.4% | 12.6% | ||
| Q1 25 | -0.2% | -1.3% | ||
| Q4 24 | -1.2% | 2.4% | ||
| Q3 24 | 0.8% | 3.9% | ||
| Q2 24 | -4.7% | 2.5% | ||
| Q1 24 | 0.7% | 4.6% |
| Q4 25 | $-2.56 | $0.23 | ||
| Q3 25 | $-0.15 | $0.31 | ||
| Q2 25 | $-0.20 | $0.99 | ||
| Q1 25 | $-0.02 | $-0.10 | ||
| Q4 24 | $-0.13 | $0.18 | ||
| Q3 24 | $0.08 | $0.30 | ||
| Q2 24 | $-0.47 | $0.17 | ||
| Q1 24 | $0.08 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $377.0M |
| Total DebtLower is stronger | — | $25.7M |
| Stockholders' EquityBook value | $322.8M | $1.9B |
| Total Assets | $449.0M | $2.4B |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $377.0M | ||
| Q3 25 | $99.1M | $386.4M | ||
| Q2 25 | $81.2M | $327.3M | ||
| Q1 25 | $80.7M | $343.9M | ||
| Q4 24 | $81.6M | $316.1M | ||
| Q3 24 | $64.0M | $319.3M | ||
| Q2 24 | $69.6M | $273.9M | ||
| Q1 24 | $5.2M | $276.0M |
| Q4 25 | — | $25.7M | ||
| Q3 25 | — | $24.9M | ||
| Q2 25 | — | $26.4M | ||
| Q1 25 | — | $20.5M | ||
| Q4 24 | — | $20.7M | ||
| Q3 24 | — | $22.2M | ||
| Q2 24 | — | $20.3M | ||
| Q1 24 | — | $20.9M |
| Q4 25 | $322.8M | $1.9B | ||
| Q3 25 | $408.1M | $1.9B | ||
| Q2 25 | $412.2M | $1.9B | ||
| Q1 25 | $418.2M | $1.8B | ||
| Q4 24 | $419.0M | $1.8B | ||
| Q3 24 | $424.7M | $1.8B | ||
| Q2 24 | $433.3M | $1.8B | ||
| Q1 24 | $462.4M | $1.7B |
| Q4 25 | $449.0M | $2.4B | ||
| Q3 25 | $538.2M | $2.5B | ||
| Q2 25 | $553.8M | $2.5B | ||
| Q1 25 | $576.2M | $2.4B | ||
| Q4 24 | $589.3M | $2.4B | ||
| Q3 24 | $597.4M | $2.4B | ||
| Q2 24 | $602.9M | $2.4B | ||
| Q1 24 | $648.4M | $2.4B |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $38.1M |
| Free Cash FlowOCF − Capex | $16.1M | $12.4M |
| FCF MarginFCF / Revenue | 6.8% | 3.2% |
| Capex IntensityCapex / Revenue | 0.9% | 6.6% |
| Cash ConversionOCF / Net Profit | — | 3.74× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $137.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $38.1M | ||
| Q3 25 | $20.1M | $79.1M | ||
| Q2 25 | $4.2M | $41.5M | ||
| Q1 25 | $5.7M | $56.7M | ||
| Q4 24 | $24.2M | $81.8M | ||
| Q3 24 | $7.5M | $54.4M | ||
| Q2 24 | $82.4M | $14.4M | ||
| Q1 24 | $6.0M | $-31.1M |
| Q4 25 | $16.1M | $12.4M | ||
| Q3 25 | $17.9M | $62.8M | ||
| Q2 25 | $2.3M | $21.1M | ||
| Q1 25 | $3.8M | $40.8M | ||
| Q4 24 | $21.7M | $62.1M | ||
| Q3 24 | $6.3M | $39.4M | ||
| Q2 24 | $79.6M | $-3.5M | ||
| Q1 24 | $3.8M | $-51.5M |
| Q4 25 | 6.8% | 3.2% | ||
| Q3 25 | 7.2% | 16.0% | ||
| Q2 25 | 0.8% | 5.8% | ||
| Q1 25 | 1.3% | 12.3% | ||
| Q4 24 | 7.0% | 18.3% | ||
| Q3 24 | 2.0% | 11.2% | ||
| Q2 24 | 23.4% | -1.1% | ||
| Q1 24 | 1.0% | -17.1% |
| Q4 25 | 0.9% | 6.6% | ||
| Q3 25 | 0.9% | 4.2% | ||
| Q2 25 | 0.7% | 5.6% | ||
| Q1 25 | 0.6% | 4.8% | ||
| Q4 24 | 0.8% | 5.8% | ||
| Q3 24 | 0.4% | 4.3% | ||
| Q2 24 | 0.8% | 5.6% | ||
| Q1 24 | 0.6% | 6.7% |
| Q4 25 | — | 3.74× | ||
| Q3 25 | — | 5.54× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 9.93× | ||
| Q3 24 | 2.92× | 3.95× | ||
| Q2 24 | — | 1.80× | ||
| Q1 24 | 2.23× | -2.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
